Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

From Breast Cancer Update by Dr. Neil Love

March 30, 2026 · 1h 16m · Season 25 · Episode 55

About this episode

Experts discuss the management of hyperglycemia in breast cancer patients receiving specific inhibitors.

Ms Jaime Carroll from Mayo Clinic in Rochester, Minnesota, Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, Dr Marie E McDonnell from Brigham and Women’s Hospital in Boston, Massachusetts, and Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss the incidence, prevention and management of hyperglycemia in breast cancer patients receiving PI3K/AKT/PTEN inhibitors. CME information and select publications  here .

People in this episode

Guests: Ms Jaime Carroll, Professor Giuseppe Curigliano, Dr Marie E McDonnell, Dr Hope S Rugo

Topics covered

  • hyperglycemia
  • breast cancer
  • PI3K/AKT/PTEN inhibitors
  • management
  • prevention
  • incidence

Keywords

  • hyperglycemia
  • breast cancer
  • PI3K
  • AKT
  • PTEN
  • management
  • prevention
  • incidence

Mentioned in this episode

Organizations: Mayo Clinic, European Institute of Oncology, Brigham and Women’s Hospital, City of Hope Comprehensive Cancer Center

Places: Rochester, Minnesota, Milan, Italy, Boston, Massachusetts, Duarte, California

More episodes of Breast Cancer Update

Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.